Qu Rong-Bo, Jin Hua
Yantai Affiliated Hospital, Department of Neurosurgery, Yantai, Shandong, China.
Turk Neurosurg. 2016;26(2):223-8. doi: 10.5137/1019-5149.JTN.7710-12.1.
To present the outcomes and follow-up results of endovascular coil embolization in patients with ophthalmic segment aneurysms (OSAs).
The data of 42 patients with 44 OSAs (7 ruptured and 37 unruptured), who underwent treatment using endovascular techniques between January 2007 and November 2010, were retrospectively reviewed.
The angiographic occlusion of the aneurysms was complete for 37 aneurysms (84.1%), near complete for 4 aneurysms (9.1%) and incomplete occlusion for 3 aneurysms (6.8%). There were 2 (4.5%) symptomatic procedure-related complications (ischemic events). One patient died of massive cerebral infarction caused by a large dissecting OSA. A favorable outcome was achieved in 97.6 % (41 of 42) of the patients at the time of follow-up. No sign of bleeding or re-bleeding was observed in any patient during the follow-up period (1 to 44 months, mean 14.2 months). Minor aneurysm recanalization occurred in 2 (4.5%) cases. The OSA-associated visual disorders completely recovered in 9 (64.3%) patients.
Endovascular treatment is a safe and effective treatment modality for intracranial OSAs.
介绍眼动脉段动脉瘤(OSA)患者血管内弹簧圈栓塞治疗的结果及随访结果。
回顾性分析2007年1月至2010年11月期间采用血管内技术治疗的42例患者的44个OSA(7个破裂,37个未破裂)的数据。
37个动脉瘤(84.1%)造影显示完全闭塞,4个动脉瘤(9.1%)接近完全闭塞,3个动脉瘤(6.8%)闭塞不完全。有2例(4.5%)出现与手术相关的症状性并发症(缺血性事件)。1例患者死于大型夹层OSA导致的大面积脑梗死。随访时97.6%(42例中的41例)的患者取得了良好的结果。随访期间(1至44个月,平均14.2个月)未观察到任何患者有出血或再出血迹象。2例(4.5%)出现小的动脉瘤再通。9例(64.3%)患者与OSA相关的视觉障碍完全恢复。
血管内治疗是颅内OSA的一种安全有效的治疗方式。